Global Monoclonal Antibodies Market 2016-2020
- SKU ID : TNV-IRTNTR9857 10292851
- |
- Publishing Date: 20-Jul-2016
- |
- Region: Global
- |
- No. of pages: 160
About Monoclonal Antibodies
Antibodies are the proteins produced by B-cells (in the bone marrow) in the immune system. These proteins attach themselves to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies, which attach themselves to different sites of an antigen. mAbs are monospecific, as they are the clones of a single parent cell. They are complex proteins with high molecular weight, and were first developed in 1975 by Kohler and Milstein.
Technavio’s analysts forecast the global monoclonal antibodies (mAbs) market to grow at a CAGR of 9.84% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global monoclonal antibodies (mAbs) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded mAbs and biosimilars used to treat cancer, autoimmune and inflammatory diseases, respiratory diseases, and ophthalmology. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market, along with the decline in revenues from the patent expiries of the marketed drugs, during the forecast period.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Monoclonal Antibodies (mAbs) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AbbVie
• Amgen
• Bristol-Myers Squibb
• F. Hoffmann-La Roche
• Johnson & Johnson
• Merck
Other prominent vendors
• AbGenomics
• ADC Therapeutics
• Agensys
• Alexion Pharmaceuticals
• ALMAC Group
• Ambrx
• Astellas Pharma
• AstraZeneca
• Bayer HealthCare
• Biogen
• Celgene
• Celldex Therapeutics
• Daiichi Sankyo
• Eisai
• Eli Lilly
• Formation Biologics
• Genmab
• GlaxoSmithKline
• Human Genome Sciences
• Immunogen
• MedImmune
• Novartis
• Pfizer
• Seattle Genetics
• Stemcentrx
• Synthon Biopharmaceuticals
• Takeda Pharmaceuticals
• Teva
• UCB
Market driver
• Special regulatory drug designations
• For a full, detailed list, view our report
Market challenge
• High manufacturing costs coupled with stringent regulations
• For a full, detailed list, view our report
Market trend
• Growing focus of vendors on untapped markets
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Antibodies are the proteins produced by B-cells (in the bone marrow) in the immune system. These proteins attach themselves to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies, which attach themselves to different sites of an antigen. mAbs are monospecific, as they are the clones of a single parent cell. They are complex proteins with high molecular weight, and were first developed in 1975 by Kohler and Milstein.
Technavio’s analysts forecast the global monoclonal antibodies (mAbs) market to grow at a CAGR of 9.84% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global monoclonal antibodies (mAbs) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded mAbs and biosimilars used to treat cancer, autoimmune and inflammatory diseases, respiratory diseases, and ophthalmology. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market, along with the decline in revenues from the patent expiries of the marketed drugs, during the forecast period.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Monoclonal Antibodies (mAbs) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AbbVie
• Amgen
• Bristol-Myers Squibb
• F. Hoffmann-La Roche
• Johnson & Johnson
• Merck
Other prominent vendors
• AbGenomics
• ADC Therapeutics
• Agensys
• Alexion Pharmaceuticals
• ALMAC Group
• Ambrx
• Astellas Pharma
• AstraZeneca
• Bayer HealthCare
• Biogen
• Celgene
• Celldex Therapeutics
• Daiichi Sankyo
• Eisai
• Eli Lilly
• Formation Biologics
• Genmab
• GlaxoSmithKline
• Human Genome Sciences
• Immunogen
• MedImmune
• Novartis
• Pfizer
• Seattle Genetics
• Stemcentrx
• Synthon Biopharmaceuticals
• Takeda Pharmaceuticals
• Teva
• UCB
Market driver
• Special regulatory drug designations
• For a full, detailed list, view our report
Market challenge
• High manufacturing costs coupled with stringent regulations
• For a full, detailed list, view our report
Market trend
• Growing focus of vendors on untapped markets
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
